BlueCrest Capital Management’s Pardes Biosciences PRDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-150,000
Closed -$1.49M – 395
2021
Q3
$1.49M Hold
150,000
– – 0.04% 234
2021
Q2
$1.5M Hold
150,000
– – 0.03% 343
2021
Q1
$1.49M Buy
+150,000
New +$1.55M 0.02% 507

Other funds holding PRDS

BlueCrest Capital Management's PRDS Position: Q4 2021 in Review

BlueCrest Capital Management sold out of Pardes Biosciences (PRDS) in Q4 2021, closing a stake of 150,000 shares — an estimated $1.49M sold.

BlueCrest Capital Management first reported a position in PRDS in Q1 2021 and held it in 3 quarters. The position peaked at $1.5M in Q2 2021. 41 funds tracked by Wall St. Rank hold PRDS as of Q4 2021.

  • BlueCrest Capital Management reported no remaining Pardes Biosciences position as of Q4 2021 after selling out during the quarter.
  • BlueCrest Capital Management sold 150,000 Pardes Biosciences shares in Q4 2021, an estimated $1.49M.
  • BlueCrest Capital Management first reported a position in Pardes Biosciences in Q1 2021 and held it in 3 quarters.
  • BlueCrest Capital Management's Pardes Biosciences position peaked at $1.5M in Q2 2021.
  • 41 funds tracked by Wall St. Rank held Pardes Biosciences as of Q4 2021.

Based on BlueCrest Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.